Sangamo Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Sangamo Therapeutics Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Sangamo Therapeutics Inc Strategy Report

  • Understand Sangamo Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Sangamo Therapeutics Inc: Segment Analysis

Business Description

Sangamo Therapeutics Inc (Sangamo) is a clinical stage biotechnology company that carries out the research, development and commercialization of genomic medicines built on its proprietary technologies. The company’s gene therapy technologies include ex vivo gene-edited cell therapy, in vivo genome regulation and in vivo genome editing.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Sangamo conducts research to develop ZFP therapeutics for neurological disorders, cancer, monogenic diseases and HIV/AIDS programs. In FY2022, the company expenses were US$249.8 million in its R&D activities, which grew 8.3% YoY. The company entered into various research agreements to use its ZFP technology to develop enhanced cell lines for protein pharmaceutical production.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward